DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $34,275,120 | +28.7% | 142,813 | +35.1% | 1.34% | +32.2% |
Q1 2023 | $26,638,108 | -5.0% | 105,690 | 0.0% | 1.01% | -4.2% |
Q4 2022 | $28,052,240 | -12.8% | 105,690 | -15.1% | 1.06% | -19.6% |
Q3 2022 | $32,172,000 | +1.9% | 124,556 | 0.0% | 1.32% | +6.1% |
Q2 2022 | $31,577,000 | -28.3% | 124,556 | -17.0% | 1.24% | -19.8% |
Q1 2022 | $44,042,000 | -33.8% | 150,145 | -25.8% | 1.55% | -27.8% |
Q4 2021 | $66,578,000 | +47.1% | 202,360 | +36.1% | 2.14% | +46.9% |
Q3 2021 | $45,265,000 | +1.5% | 148,683 | -10.6% | 1.46% | +0.6% |
Q2 2021 | $44,612,000 | +3.6% | 166,240 | -13.1% | 1.45% | -2.1% |
Q1 2021 | $43,044,000 | -11.9% | 191,240 | -13.0% | 1.48% | -13.7% |
Q4 2020 | $48,835,000 | +235.7% | 219,840 | +225.4% | 1.72% | +214.9% |
Q3 2020 | $14,549,000 | -48.4% | 67,567 | -57.6% | 0.54% | -49.2% |
Q2 2020 | $28,178,000 | +27.8% | 159,352 | 0.0% | 1.07% | +7.5% |
Q1 2020 | $22,056,000 | -13.2% | 159,352 | -3.7% | 1.00% | +3.9% |
Q4 2019 | $25,397,000 | +15.4% | 165,476 | +8.6% | 0.96% | 0.0% |
Q3 2019 | $22,008,000 | -3.1% | 152,376 | -4.1% | 0.96% | +3.6% |
Q2 2019 | $22,714,000 | +8.3% | 158,931 | 0.0% | 0.93% | +8.8% |
Q1 2019 | $20,982,000 | -2.8% | 158,931 | -24.1% | 0.85% | -7.8% |
Q4 2018 | $21,590,000 | -5.1% | 209,371 | 0.0% | 0.92% | +12.0% |
Q3 2018 | $22,750,000 | +19.5% | 209,371 | +8.6% | 0.82% | +14.3% |
Q2 2018 | $19,033,000 | +159.7% | 192,871 | +157.7% | 0.72% | +153.3% |
Q1 2018 | $7,328,000 | +419.3% | 74,847 | +392.3% | 0.28% | +427.8% |
Q4 2017 | $1,411,000 | – | 15,203 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |